SBIR/STTR Research Award
Electrical circuit prototype for nanoscale intracellular neural recording device
Award amount
$158,895Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- GALIANA TECHNOLOGY, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PA14-071
- Topic code
- NIDA
Research abstract
DESCRIPTION (provided by applicant): We are developing nanoscale electronic circuits (nanofids) that will be implanted into millions of neurons to record neural activity during behavior. Our long-term goal is to record high-resolution neural activity information during acquisition and expression of learned behavioral models of addiction. The long-term health goal is to identify neuronal ensembles encoding addiction-related memories for eventual ablation. In this application, we are developing semiconductorchip prototypes that will transmit near-infrared (NIR) signals with unique frequency identification whenever intracellular calcium levels rise above a set threshold corresponding to neural activation. We are assessing power requirements and biocompatibility of the overall circuit and individual circuit components in air and intracellular model solutions. Signal attenuation of NIR output will be assessed in these solutions using NIR spectrometry. In future, the optimized circuit from this application will be
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)